equol has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZK; Ma, DF; Wang, Y; Yu, X; Zou, YQ | 1 |
| Belosay, A; Doerge, DR; Hartman, JA; Helferich, WG; Song, H; Wang, W; Yang, X; Zhang, Y | 1 |
2 other study(ies) available for equol and Lung Neoplasms
| Article | Year |
|---|---|
[Equol and its enantiomers inhibited urethane-induced lung cancer in mice].
Topics: Animals; Body Weight; Equol; Genistein; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Superoxide Dismutase; Urethane | 2022 |
Dietary soy isoflavones increase metastasis to lungs in an experimental model of breast cancer with bone micro-tumors.
Topics: Animals; Anticarcinogenic Agents; Bone Neoplasms; Breast Neoplasms; Cell Proliferation; Diet; Dietary Supplements; Disease Models, Animal; Equol; Female; Genistein; Isoflavones; Ki-67 Antigen; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Neoplasm Transplantation; Prognosis; Random Allocation; Soy Foods | 2015 |